(Q71236279)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7389058%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

title

Low-dose cyclophosphamide versus adriamycin plus cyclophosphamide in advanced ovarian cancer. A randomized clinical study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7389058%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7389058%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

author name string

G Bolis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7389058%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

G Bortolozzi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7389058%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

G Carinelli

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7389058%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

F Gramellini

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7389058%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

L Morasca

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7389058%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

C Mangioni

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7389058%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

publication date

1 January 1980

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7389058%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

17 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7389058%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7389058%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7389058%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

page(s)

129-132

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7389058%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00254034

17 October 2019

exact match

0 references

cites work

The CHAD and HAD regimens in advanced ovarian cancer: combination chemotherapy including cyclophosphamide, hexamethylmelamine, adriamycin, and cis-dichlorodiammineplatinum(II)

1 reference

12 December 2020

Different chemotherapeutic sensitivities and host factors affecting prognosis in advanced ovarian carcinoma versus minimal residual disease

1 reference

12 December 2020

Chemotherapy of advanced ovarian carcinoma: a prospective randomized comparison of phenylalanine mustard and high dose cyclophosphamide

1 reference

12 December 2020

Combination chemotherapy with adriamycin (NSC-123127) and cyclophosphamide (NSC-26271) for solid tumors: a phase II trial

1 reference

12 December 2020

Melphalan versus adriamycin in the treatment of advanced carcinoma of the ovary

1 reference

12 December 2020

Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma

1 reference

12 December 2020

Randomized study of chemoimmunotherapy for advanced ovarian carcinoma: a preliminary report of a Southwest Oncology Group study

1 reference

12 December 2020

Continuous low-dose cyclophosphamide (NSC-26271) therapy in advanced ovarian cancer

1 reference

12 December 2020

Prognostic importance of histologic grading in ovarian carcinoma

1 reference

12 December 2020

Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy

1 reference

12 December 2020

Lymphangiography in patients with ovarian epithelial cancer.An evaluation of 289 consecutive cases

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00254034

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7389058%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

1 reference